建立青春期痴呆症的黄金标准评估:基于澳大利亚的修改后的E-Delphi共识调查
Josyane Lau1, Monica Cations2, Mary O'Malley3
1University of Notre Dame, Sydney, Australia.
International journal of geriatric psychiatry
|December 9, 2024
概括
澳大利亚临床医生就年轻发病痴呆症 (YOD) 的关键评估标准达成共识,与国际专家保持一致. 这项研究确立了澳大利亚YOD诊断的最低标准和黄金标准.
科学领域:
- 神经学 神经学
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
背景情况:
- 年轻发病痴呆症 (YOD) 需要特定的诊断标准来准确和及时评估.
- 现有的国际指导方针可能无法充分捕捉澳大利亚临床背景下YOD诊断的细微差别.
- 建立基于共识的标准对于改善诊断一致性和患者护理至关重要.
研究的目的:
- 为澳大利亚临床医生制定针对年轻发病痴呆症 (YOD) 的最低标准和黄金标准评估.
- 通过使用修改后的e-Delphi方法,探索有关YOD基本诊断标准的专家共识.
- 为了比较澳大利亚专家的意见与国际发现的YOD评估.
主要方法:
- 采用了经过修改的e-Delphi方法,包括向澳大利亚临床专家分发的在线调查.
- 从一项国际研究中改编的72个陈述在利克尔特等级 (1-7) 上被评为重要.
- 共识被定义为"最低标准" (100%对重要/非常重要的协议) 和"黄金标准" (80%的协议).
主要成果:
- 在13个陈述上达成全面共识 ("最低标准"),在37个陈述上达成高度共识 ("黄金标准").
- 临床医生强调患者病史在YOD诊断中的重要性,不太重视检查和调查.
- 常规痴呆症血液查和基线结构成像被认为是必要的诊断组件.
结论:
- 该研究确定了37个关于青少年日的评估的共识陈述,这些陈述在很大程度上与国际专家意见一致.
- 这些发现为澳大利亚临床医生在评估和诊断YOD时提供了有价值的框架.
- 未来的研究应该考虑澳大利亚特定的背景,如澳大利亚原住民和农村人口的YOD,以及不断发展的诊断知识.
相关概念视频
Dementia
96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
96
Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447


